cagrilintide semaglutide combination phase 3 2024 Novo Nordisk has officially filed for FDA approval of CagriSema, a powerful new once-weekly injection that combines a GLP-1 receptor agonist with an amylin analogue, setting the stage for the next major Low stock

bpc-157 gut healing peptide PURE Oral Spray Color:Ivory White Muscle Health IGF-1 LR3 + Acetic –

Instead of temporarily boosting energy like caffeine, nootropic peptides work by regulating brain chemistry and improving how your brain functions over time

Low stock

Variant:25mg

Among the twelve peptides removed from the Category 2 list (effective April 23, 2026): Removal from Category 2 is separate from the FDA’s review of which peptides may be compounded under section 503A